{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:17Z","timestamp":1781636057940,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mevalonate kinase deficiency (MKD) is a rare genetic disorder, resulting in the lack of the mevalonate kinase enzyme (MVK), which is involved in the biosynthesis of cholesterol, non-sterol isoprenoids, and coenzyme Q10 (CoQ10). The more severe phenotype of MKD is known as mevalonic aciduria (MA), typically presenting as a multisystemic inflammatory syndrome with possible neurological manifestations, such as developmental delay, cerebellar ataxia, and retinopathy. Myopathy or isolated hyperCKemia have been rarely reported in association with MA. However, a few studies evidenced mitochondrial dysfunction in MVK deficient cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To point out the connection between MKD, myopathy, and mitochondrial dysfunction, describing two cases of MA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We report on two unrelated patients with myopathy and ataxia, providing clinical, histological, biochemical, and genetic data of MKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both patients were referred to the Neurology Department in the first year of life, due to muscle weakness, gait disturbances, and increased levels of CK value. Muscle biopsy was performed, showing some mitochondrial alterations and mild lipid storage. Interestingly, biochemical studies on muscle homogenate revealed a reduction of mitochondrial respiratory chain activities and CoQ10 levels. Genetic analysis confirmed the MKD diagnosis, evidencing a homozygous\n                      <jats:italic>MVK<\/jats:italic>\n                      gene mutation in the first case, and compound heterozygous mutations in the second one.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report describes two MKD cases with clinical and morphological evidence of muscle involvement in the spectrum of MA related to mitochondrial dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04248-y","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:52:20Z","timestamp":1770904340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myopathy and ataxia related to impaired mitochondrial function in mevalonate kinase deficiency"],"prefix":"10.1186","volume":"21","author":[{"given":"Alessia","family":"Pugliese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"von Landenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Gallizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Migliorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabata","family":"Pierno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio Giuseppe","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram S.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9208-1527","authenticated-orcid":false,"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"4248_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/BOR.0b013e328349c3b1","volume":"23","author":"M Stoffels","year":"2011","unstructured":"Stoffels M, Simon A. Hyper-IgD syndrome or mevalonate kinase deficiency. Curr Opin Rheumatol. 2011;23:419\u201323. https:\/\/doi.org\/10.1097\/BOR.0b013e328349c3b1.","journal-title":"Curr Opin Rheumatol"},{"key":"4248_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","volume":"14","author":"S Zhang","year":"2016","unstructured":"Zhang S. Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol. 2016;14:30. https:\/\/doi.org\/10.1186\/s12969-016-0091-7.","journal-title":"Pediatr Rheumatol"},{"key":"4248_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/TACG.S93933","volume":"9","author":"G Schulert","year":"2016","unstructured":"Schulert G, Favier L. Mevalonate kinase deficiency: current perspectives. Appl Clin Genet Volume. 2016;9:101\u201310. https:\/\/doi.org\/10.2147\/TACG.S93933.","journal-title":"Appl Clin Genet Volume"},{"key":"4248_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","volume":"147","author":"R van der Burgh","year":"2013","unstructured":"van der Burgh R, ter Haar NM, Boes ML, Frenkel J. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol. 2013;147:197\u2013206. https:\/\/doi.org\/10.1016\/j.clim.2012.09.011.","journal-title":"Clin Immunol"},{"key":"4248_CR5","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","volume":"68","author":"NM ter Haar","year":"2016","unstructured":"ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: A series of 114 cases from the Eurofever registry. Arthritis Rheumatol. 2016;68:2795\u2013805. https:\/\/doi.org\/10.1002\/art.39763.","journal-title":"Arthritis Rheumatol"},{"key":"4248_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/13816810.2016.1227459","volume":"38","author":"U Kellner","year":"2017","unstructured":"Kellner U, St\u00f6hr H, Weinitz S, et al. Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations. Ophthalmic Genet. 2017;38:340\u20134. https:\/\/doi.org\/10.1080\/13816810.2016.1227459.","journal-title":"Ophthalmic Genet"},{"key":"4248_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2022.04.006","volume":"136","author":"I Elhani","year":"2022","unstructured":"Elhani I, Hentgen V, Grateau G, Georgin-Lavialle S. Neurological manifestations in mevalonate kinase deficiency: A systematic review. Mol Genet Metab. 2022;136:85\u201393. https:\/\/doi.org\/10.1016\/j.ymgme.2022.04.006.","journal-title":"Mol Genet Metab"},{"key":"4248_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jmd2.12348","volume":"64","author":"EMM van Hoytema","year":"2023","unstructured":"van Hoytema EMM, Oussoren E, Frenkel J, van Hasselt PM. Isolated neurological presentations of mevalonate kinase deficiency. JIMD Rep. 2023;64:53\u20136. https:\/\/doi.org\/10.1002\/jmd2.12348.","journal-title":"JIMD Rep"},{"key":"4248_CR9","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1016\/j.mito.2007.02.009","volume":"7","author":"IP Hargreaves","year":"2007","unstructured":"Hargreaves IP. Coenzyme Q10 in phenylketonuria and mevalonic aciduria. Mitochondrion. 2007;7:S175\u201380. https:\/\/doi.org\/10.1016\/j.mito.2007.02.009.","journal-title":"Mitochondrion"},{"key":"4248_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ana.410220409","volume":"22","author":"S DiMauro","year":"1987","unstructured":"DiMauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol. 1987;22:498\u2013506. https:\/\/doi.org\/10.1002\/ana.410220409.","journal-title":"Ann Neurol"},{"key":"4248_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cge.12742","volume":"90","author":"E Barca","year":"2016","unstructured":"Barca E, Musumeci O, Montagnese F, et al. Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3. Clin Genet. 2016;90:156\u201360. https:\/\/doi.org\/10.1111\/cge.12742.","journal-title":"Clin Genet"},{"key":"4248_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0003-2697(86)90203-4","volume":"157","author":"JK Lang","year":"1986","unstructured":"Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem. 1986;157:106\u201316. https:\/\/doi.org\/10.1016\/0003-2697(86)90203-4.","journal-title":"Anal Biochem"},{"key":"4248_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","volume":"12","author":"R Papa","year":"2017","unstructured":"Papa R, Doglio M, Lachmann HJ, et al. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis. 2017;12:167. https:\/\/doi.org\/10.1186\/s13023-017-0720-3.","journal-title":"Orphanet J Rare Dis"},{"key":"4248_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ejhg.5200595","volume":"9","author":"SM Houten","year":"2001","unstructured":"Houten SM, Koster J, Romeijn G-J, et al. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Hum Genet. 2001;9:253\u20139. https:\/\/doi.org\/10.1038\/sj.ejhg.5200595.","journal-title":"Eur J Hum Genet"},{"key":"4248_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","volume":"87","author":"JCH van der Hilst","year":"2008","unstructured":"van der Hilst JCH, Bodar EJ, Barron KS, et al. Long-Term Follow-Up, clinical Features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301\u201310. https:\/\/doi.org\/10.1097\/MD.0b013e318190cfb7.","journal-title":"Medicine"},{"key":"4248_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/jcm10081552","volume":"10","author":"G Boursier","year":"2021","unstructured":"Boursier G, Rittore C, Milhavet F, et al. Mevalonate Kinase-Associated diseases: hunting for Phenotype\u2013Genotype correlation. J Clin Med. 2021;10:1552. https:\/\/doi.org\/10.3390\/jcm10081552.","journal-title":"J Clin Med"},{"key":"4248_CR17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1212\/01.WNL.0000115390.33405.F7","volume":"62","author":"A Simon","year":"2004","unstructured":"Simon A, Kremer HPH, Wevers RA, et al. Mevalonate kinase deficiency. Neurology. 2004;62:994\u20137. https:\/\/doi.org\/10.1212\/01.WNL.0000115390.33405.F7.","journal-title":"Neurology"},{"key":"4248_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/jimd.12412","volume":"44","author":"H Brennenstuhl","year":"2021","unstructured":"Brennenstuhl H, Nashawi M, Schr\u00f6ter J, et al. Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria. J Inherit Metab Dis. 2021;44:1272\u201387. https:\/\/doi.org\/10.1002\/jimd.12412.","journal-title":"J Inherit Metab Dis"},{"key":"4248_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10545-009-1150-8","volume":"32","author":"D Haas","year":"2009","unstructured":"Haas D, Niklowitz P, H\u00f6rster F, et al. Coenzyme Q (10) is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis. 2009;32:570\u20135. https:\/\/doi.org\/10.1007\/s10545-009-1150-8.","journal-title":"J Inherit Metab Dis"},{"key":"4248_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1056\/NEJM198606193142504","volume":"314","author":"G Hoffmann","year":"1986","unstructured":"Hoffmann G, Gibson KM, Brandt IK, et al. Mevalonic aciduria: an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med. 1986;314:1610\u20134. https:\/\/doi.org\/10.1056\/NEJM198606193142504.","journal-title":"N Engl J Med"},{"key":"4248_CR21","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00294-018-0803-2","volume":"64","author":"MMS Santos","year":"2018","unstructured":"Santos MMS, Elsztein C, De Souza RB, et al. Respiratory deficiency in yeast mevalonate kinase deficient May explain MKD-associate metabolic disorder in humans. Curr Genet. 2018;64:871\u201381. https:\/\/doi.org\/10.1007\/s00294-018-0803-2.","journal-title":"Curr Genet"},{"key":"4248_CR22","doi-asserted-by":"publisher","first-page":"166053","DOI":"10.1016\/j.bbadis.2020.166053","volume":"1867","author":"MMS Santos","year":"2021","unstructured":"Santos MMS, Gatica D, de Az\u00eavedo Silva J, et al. Incomplete mitophagy in the mevalonate kinase-deficient Saccharomyces cerevisiae and its relation to the MKD-related autoinflammatory disease in humans. Biochimica et biophysica acta (BBA) -. Mol Basis Disease. 2021;1867:166053. https:\/\/doi.org\/10.1016\/j.bbadis.2020.166053.","journal-title":"Mol Basis Disease"},{"key":"4248_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1542\/peds.91.5.915","volume":"91","author":"G Hoffmann","year":"1993","unstructured":"Hoffmann G, Charpentier C, Mayatepek E. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91:915\u201321.","journal-title":"Pediatrics"},{"key":"4248_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1203\/00006450-199308000-00004","volume":"34","author":"C H\u00fcbner","year":"1993","unstructured":"H\u00fcbner C, Hoffmann GF, Charpentier C, et al. Decreased plasma Ubiquinone-10 concentration in patients with mevalonate kinase deficiency. Pediatr Res. 1993;34:129\u201333. https:\/\/doi.org\/10.1203\/00006450-199308000-00004.","journal-title":"Pediatr Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04248-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:10:44Z","timestamp":1781633444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04248-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4248"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04248-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and written consent to participate was obtained. This study was approved by the Ethic Committee of the University Hospital \u201cG. Martino\u201d of Messina, Italy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants gave informed consent for data disclosure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable. All the authors have read and approved the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}